MARKET WIRE NEWS

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

MWN-AI** Summary

As of February 28, 2026, the total number of shares and voting rights for the company listed on the NYSE Euronext Paris under ISIN code FR 0010417345 has been officially reported. The company holds a total of 278,352,082 shares. Correspondingly, the total gross voting rights associated with these shares also amounts to 278,352,082.

However, it is important to note that the total net voting rights, which accounts for shares that are devoid of voting rights, stands at 278,236,200. The distinction between gross and net voting rights is crucial for investors and stakeholders; while gross voting rights represent all shares, net voting rights exclude those shares that do not carry the right to vote, affecting decision-making and governance within the company.

This information adheres to Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (AMF) and is essential for investors to understand the company’s voting structure. The total number of voting rights impacts shareholder influence and corporate governance, particularly during annual general meetings or significant corporate decisions, where voting power is integral.

As such, this data point not only helps in financial evaluations but also aids prospective and current investors in grasping the level of their influence on future corporate directions. The transparent disclosure of such information reinforces regulatory compliance and enhances market confidence in the company’s operations.

MWN-AI** Analysis

As of February 28, 2026, the company listed under ISIN Code FR 0010417345 on NYSE Euronext Paris reported a total of 278,352,082 shares and 278,236,200 net voting rights. This detail indicates a minor disparity between the total gross voting rights and the net voting rights, signifying the existence of shares without voting rights, which stands at approximately 115,882 shares.

From a market perspective, the relatively high number of total shares indicates a significant capitalization, reflecting a healthy investor interest and liquidity in the stock. However, the presence of shares without voting rights may raise concerns regarding governance from minority shareholders, potentially impacting investor sentiment.

Investors should analyze the implications of this voting structure. Companies that allocate a portion of shares without voting rights may be perceived as potentially less democratic, which can affect stock price volatility and long-term valuation. If the issuer’s corporate governance policies are robust, this may mitigate concerns among shareholders and sustain investor confidence.

A scrutiny of the company's current and projected earnings, alongside its strategic goals, is essential. Given the total voting rights remain unchanged relative to the number of shares, it is crucial to consider the company's performance metrics, trading volume, and market position amid economic indicators.

In summary, while the number of total shares indicates strength, investors are advised to remain cautious regarding governance structures. Implementing a proactive engagement approach with the company may provide reassurance. Monitoring any changes in voting rights distribution or corporate governance practices will be essential, as these factors could influence stock performance and overall market perception going forward.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

Information Regarding the Total Number of Voting Rights and 
Total Number of Shares of the Company as of February 28, 2026

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
02/28/2026

 
278,352,082

 
 

Total gross of voting rights: 278,352,082

 
 

Total net* of voting rights: 278,236,200

 

* Net total = total number of voting rights attached to shares – shares without voting rights

Attachment


FAQ**

What factors contributed to the discrepancies between the total gross and net voting rights for Dbv Techs Boulogne Bill DBVTF on February 28, 2026?

The discrepancies between the total gross and net voting rights for DBV Technologies' Boulogne Bill DBVTF on February 28, 2026, were primarily due to the effects of treasury shares, shareholder restrictions, and regulatory adjustments affecting voting entitlements.

How does the total number of shares (278,352,08for Dbv Techs Boulogne Bill DBVTF compare to prior periods, and what implications might this have for shareholder engagement?

The total number of shares for DBV Technologies (278,352,082) reflects a potential dilution or increase in liquidity compared to prior periods, which could enhance shareholder engagement by attracting new investors but may also dilute existing ownership stakes.

Can you provide insights into the types of shares that are classified as having no voting rights within Dbv Techs Boulogne Bill DBVTF?

In DBV Technologies, shares classified as having no voting rights typically include preferred shares or certain classes of common stock that are designed for investors focused on dividends rather than participating in company governance.

What strategies does the company plan to implement to potentially increase the total number of voting rights in future reporting periods for Dbv Techs Boulogne Bill DBVTF?

DBV Technologies plans to increase total voting rights by pursuing strategic partnerships, potentially increasing funding through equity offerings, and enhancing shareholder engagement initiatives to drive interest and participation in future voting processes.

**MWN-AI FAQ is based on asking OpenAI questions about DBV Technologies S.A. (NASDAQ: DBVT).

DBV Technologies S.A.

NASDAQ: DBVT

DBVT Trading

0.37% G/L:

$23.27 Last:

151,605 Volume:

$23.35 Open:

mwn-ir Ad 300

DBVT Latest News

DBVT Stock Data

$801,767,672
33,335,677
74.36%
21
N/A
Biotechnology & Life Sciences
Healthcare
FR
Chtillon

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App